Kolendowski, B.; Valdes, Y.R.; Hirte, H.; Itamochi, H.; Lee, W.; Carey, M.; Shepherd, T.G.; DiMattia, G.E.
Characterization of Mutational Status, Spheroid Formation, and Drug Response of a New Genomically-Stable Human Ovarian Clear Cell Carcinoma Cell Line, 105C. Cells 2020, 9, 2408.
https://doi.org/10.3390/cells9112408
AMA Style
Kolendowski B, Valdes YR, Hirte H, Itamochi H, Lee W, Carey M, Shepherd TG, DiMattia GE.
Characterization of Mutational Status, Spheroid Formation, and Drug Response of a New Genomically-Stable Human Ovarian Clear Cell Carcinoma Cell Line, 105C. Cells. 2020; 9(11):2408.
https://doi.org/10.3390/cells9112408
Chicago/Turabian Style
Kolendowski, Bart, Yudith Ramos Valdes, Hal Hirte, Hiroaki Itamochi, Wonjae Lee, Mark Carey, Trevor G. Shepherd, and Gabriel E. DiMattia.
2020. "Characterization of Mutational Status, Spheroid Formation, and Drug Response of a New Genomically-Stable Human Ovarian Clear Cell Carcinoma Cell Line, 105C" Cells 9, no. 11: 2408.
https://doi.org/10.3390/cells9112408
APA Style
Kolendowski, B., Valdes, Y. R., Hirte, H., Itamochi, H., Lee, W., Carey, M., Shepherd, T. G., & DiMattia, G. E.
(2020). Characterization of Mutational Status, Spheroid Formation, and Drug Response of a New Genomically-Stable Human Ovarian Clear Cell Carcinoma Cell Line, 105C. Cells, 9(11), 2408.
https://doi.org/10.3390/cells9112408